Performance Assessement for Paralympic Athletes (PARAPERF)

March 21, 2022 updated by: Assistance Publique - Hôpitaux de Paris

Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports

The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.

The secondary objectives of the study:

  • quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
  • quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
  • quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
  • quantification and mechanical monitoring by the made-to-measure or usual sportive material.

Study Overview

Detailed Description

The sportive performance results from a range of determinations such as: physiological, biomechanical, morphological, psychological, social and environmental factors. The interactions between athletes, equipment, training and environment influences the development of athletes' performance. In the context of the coming Paris 2024 Paralympic Games, the performance construction for the exploration, the quantification and the management of all factors is an commun objective between sportive team, medical team and researchers.

Study Type

Interventional

Enrollment (Anticipated)

134

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Garches, France, 92380
        • Recruiting
        • Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
  • Aged >= 14 years;
  • Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
  • Covered by social security system.

Exclusion Criteria:

  • Temporary or definitive contraindication to the practice of the affected sport activity;
  • Undergoing anti-coagulated treatments;
  • Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
  • Under guardianship or judicial decision;
  • Ongoing pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Parasportives of various disciplines

Standardization of evaluation and clinical and sportive follow-up of athletes.

Made-to-measure technical supports will be tested regarding the Paralympic regulations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic sportive activity
Time Frame: through study completion, an average of 1 year
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
through study completion, an average of 1 year
Dynamic sportive activity
Time Frame: at 42 months
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
at 42 months
Static sportive activity
Time Frame: through study completion, an average of 1 year
Static sportive activity: maximal speed of movement of pression center.
through study completion, an average of 1 year
Static sportive activity
Time Frame: at 42 months
Static sportive activity: maximal speed of movement of pression center.
at 42 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biomechanical indices of performance: isometric power measurement
Time Frame: through study completion, an average of 1 year
Isometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort.
through study completion, an average of 1 year
Biomechanical indices of performance: arms and shoulder's Strength
Time Frame: through study completion, an average of 1 year
Arms and shoulder's Strength will be measured by force platform.
through study completion, an average of 1 year
Physiological indices of performance: maximal aerobic speed (MAS)
Time Frame: Twice through study completion, an average of 42 months
Maximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer.
Twice through study completion, an average of 42 months
Physiological indices of performance: maximal aerobic power
Time Frame: Twice through study completion, an average of 42 months
Maximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test.
Twice through study completion, an average of 42 months
Fatigue assessment
Time Frame: Twice through study completion, an average of 42 months
Fatigue assessment will be measured by Fatigue Index (Power max ratio).
Twice through study completion, an average of 42 months
Blood lactate concentration
Time Frame: immediately after the intervention
Blood lactatemia level will be measured by lactometer.
immediately after the intervention
VO2 peak oxygen uptake
Time Frame: through study completion, an average of 1 year
VO2 peak oxygen uptake
through study completion, an average of 1 year
Peak breath expiration volume assessment
Time Frame: through study completion, an average of 1 year
VE peak: peak breath expiration volume
through study completion, an average of 1 year
Peak cardiac frequence
Time Frame: through study completion, an average of 1 year
CF: peak cardiac frequence
through study completion, an average of 1 year
Musculo-squeletic troubles risks measurement
Time Frame: through study completion, an average of 1 year
Musculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e. "Constant scale").
through study completion, an average of 1 year
Time and distance of deceleration of wheelchair during riding test
Time Frame: through study completion, an average of 1 year
Time and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units).
through study completion, an average of 1 year
Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsion
Time Frame: through study completion, an average of 1 year
Applied forces on handrim during the propulsion: measured by force platform.
through study completion, an average of 1 year
Acceleration profil during the propulsion
Time Frame: through study completion, an average of 1 year
through study completion, an average of 1 year
Speed profil during the propulsion
Time Frame: through study completion, an average of 1 year
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: François Genêt, MD, PhD, Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
  • Study Director: Jean François Toussaint, MD, PhD, Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2021

Primary Completion (Anticipated)

June 1, 2024

Study Completion (Anticipated)

June 1, 2024

Study Registration Dates

First Submitted

December 11, 2020

First Submitted That Met QC Criteria

February 6, 2021

First Posted (Actual)

February 10, 2021

Study Record Updates

Last Update Posted (Actual)

March 22, 2022

Last Update Submitted That Met QC Criteria

March 21, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • APHP201139
  • 2020-A02919-30 (Registry Identifier: IDRCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Paralympic Athletes

Clinical Trials on Standardization of evaluation and follow-up

3
Subscribe